Close Menu

NEW YORK (GenomeWeb) – Cancer Genetics today announced it has received conditional licensure from the New York State Department of Health for its FISH-based HPV-Associated Cancer Test (FHACT) for cervical cancer.

The test, which received US approval as a laboratory-developed test under CLIA in late 2013, assesses genomic changes often found in cervical cancers and can identify women who are at higher risk for disease progression, the firm said in a statement. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.

Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.

One gene regulates hundreds of others to influence facial development, according to New Scientist.

In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.